SLC22A3 and acute myeloid leukemia: To date, many research works have indicated the association between SLC22A3 and cancers, including tumorigenesis, tumor invasion and metastasis, uptake and metabolism of antineoplastic drugs, and disease prognosis [16–22], but the significance of SLC22A3 in AML remains unclear so far.